Search details
1.
Flau-A, a naphthoquinone derivative, is a promising therapeutic candidate against visceral leishmaniasis: A preliminary study.
Exp Parasitol
; 233: 108205, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34968460
2.
Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis.
Parasitol Res
; 120(1): 321-335, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-33191446
3.
Synthesis and cytotoxicity evaluation of glycosidic derivatives of lawsone against breast cancer cell lines.
Bioorg Med Chem Lett
; 30(2): 126817, 2020 01 15.
Article
in English
| MEDLINE | ID: mdl-31810778
4.
Enhanced antitumor efficacy of lapachol-loaded nanoemulsion in breast cancer tumor model.
Biomed Pharmacother
; 133: 110936, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-33254016
5.
In vitro and in vivo antileishmanial activity of ß-acetyl-digitoxin, a cardenolide of Digitalis lanata potentially useful to treat visceral leishmaniasis.
Parasite
; 28: 38, 2021.
Article
in English
| MEDLINE | ID: mdl-33851916
6.
A clioquinol-containing Pluronic® F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine model.
Parasite
; 27: 29, 2020.
Article
in English
| MEDLINE | ID: mdl-32351209
7.
A Pluronic® F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infection.
Parasitol Int
; 68(1): 63-72, 2019 Feb.
Article
in English
| MEDLINE | ID: mdl-30339837
8.
In vivo antileishmanial efficacy of a naphthoquinone derivate incorporated into a Pluronic® F127-based polymeric micelle system against Leishmania amazonensis infection.
Biomed Pharmacother
; 109: 779-787, 2019 Jan.
Article
in English
| MEDLINE | ID: mdl-30551531
Results
1 -
8
de 8
1
Next >
>>